STOCK TITAN
  1. Home
  2. Sec-filings
  3. CGON
  4. [144] CG Oncology, Inc. Common stock SEC Filing

[144] CG Oncology, Inc. Common stock SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CGON logo
CG Oncology, Inc.

NASDAQ:CGON

CGON Rankings

#2058 Ranked by Market Cap
N/A Ranked by Dividends

CGON Latest News

Sep 3, 2025
CG Oncology Completes Enrollment in PIVOT-006
Aug 29, 2025
CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences
Aug 8, 2025
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
Jul 29, 2025
Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals
Jun 5, 2025
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

CGON Latest SEC Filings

Sep 3, 2025
[144] CG Oncology, Inc. Common stock SEC Filing
Sep 3, 2025
[144] CG Oncology, Inc. Common stock SEC Filing
Aug 8, 2025
[10-Q] CG Oncology, Inc. Common stock Quarterly Earnings Report
Aug 8, 2025
[8-K] CG Oncology, Inc. Common stock Reports Material Event
Aug 6, 2025
[Form 3] CG Oncology, Inc. Common stock Initial Statement of Beneficial Ownership

CGON Stock Data

2.04B
69.49M
1.17%
112.44%
14.44%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
IRVINE